American Society of Hematology

SHERPA: Blue

People

  1. Van Den Brink
    Van Den Brink
  2. Hanash
    Hanash
  3. Hsu
    Hsu
  4. Giralt
    Giralt
  5. Papadopoulos
    Papadopoulos
  6. Perales
    Perales
  7. O'Reilly
    O'Reilly
  8. Castro-Malaspina
    Castro-Malaspina
  9. Jakubowski
    Jakubowski
  10. Levine
    Levine

Groups

  1. Bone Marrow Transplant (92)
  2. Center for Hematologic Malignancies (92)
  3. Department of Medicine (92)
  4. Human Oncology and Pathogenesis Program (92)
  5. GSK Faculty (90)
  6. Hematologic Malignancies, Division of (76)
  7. Executive Committee, Center for Hematologic Malignancies (57)
  8. Hematologic Malignancies Research (51)
  9. Tow Center for Developmental Oncology (TCDO) (44)
  10. Sloan Kettering Institute Faculty (41)
Search Within
  1. "Meeting abstract"
  2. "Human Oncology and Pathogenesis Program"
  3. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (92)
Groups
  1. Bone Marrow Transplant (92)
  2. Center for Hematologic Malignancies (92)
  3. Department of Medicine (92)
  4. Human Oncology and Pathogenesis Program (92)
  5. GSK Faculty (90)
  6. Hematologic Malignancies, Division of (76)

More Groups

People
  1. Marcel Van Den Brink (35)
  2. Alan Hanash (30)
  3. Katharine Hsu (30)
  4. Esperanza Papadopoulos (19)
  5. Sergio Giralt (19)
  6. Miguel-Angel Perales (18)

More People

Years
  1. 2023 (4)
  2. 2022 (5)
  3. 2021 (1)
  4. 2020 (4)
  5. 2019 (4)
  6. 2018 (7)

More Years

Publications
  1. Blood (92)

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Camacho-Bydume, C.; Wang, T.; Chowell, D.; Krishna, C.; Shaffer, B. C.; Marsh, S.; Paczesny, S.; Gadalla, S. M.; He, M.; Bolon, Y. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • IL-33 induces Paneth cell production of EGF and soluble ST2, regulating epithelial regeneration after intestinal injury
    Meeting Abstract

    Calafiore, M.; Fu, Y. Y.; Vinci, P.; Arnhold, V.; Chang, W.; Jansen, S.; Egorova, A.; Takashima, S.; Kuttiyara, J.; Ito, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Immune escape after allogeneic hematopoietic cell transplantation in pediatric patients with acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Ceglia, N.; Le Luduec, J. B.; McPherson, A.; Spitzer, B.; Bojilova, V.; Panjwani, M. K.; Roshal, M.; Shah, S.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Attenuation of graft-versus-host-disease via genetic or pharmacologic inhibition of the RNA splicing factor RBM39
    Meeting Abstract

    Bourcier, J.; Hogg, S. J.; Erickson, C.; Singer, M. E.; Tittley, S.; Ito, T.; Egorova, A.; Kuttiyara, J.; Hanash, A. M.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Donor-derived amphiregulin drives CD4(+) T cell expansion and promotes tissue pathology after experimental allogeneic BMT
    Meeting Abstract

    Ito, T.; Takashima, S.; Calafiore, M.; Fu, Y. Y.; Egorova, A.; Kuttiyara, J.; Chang, W.; Vinci, P.; Arnhold, V.; Zaiss, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save